FATF AML Recommendations for Pharmaceuticals & Life Sciences
What FATF AML Recommendations means for Pharmaceuticals & Life Sciences organizations — and how we implement it at the architecture level.
FATF AML Recommendations in Pharmaceuticals & Life Sciences environments carries requirements that go beyond the framework's general provisions. The specific operations of Pharmaceuticals & Life Sciences organizations — their data processing scale, their regulatory relationships, and their operational dependencies — create compliance obligations that engineering teams must address at the architecture level. Generic FATF AML Recommendations compliance that ignores the Pharmaceuticals & Life Sciences context will produce a system that passes audit by a framework-generalist but fails review by an industry-specialist examiner.
Our teams deploy in Pharmaceuticals & Life Sciences environments with FATF AML Recommendations compliance built into the architecture from the first design decision. The compliance controls are not a layer added to an existing system — they are implemented as first-class components that generate evidence continuously as the system operates. The result is a system that is compliant on deployment day, remains compliant as it evolves, and produces audit evidence without manual assembly.
FATF AML Recommendations compliance documentation maintained as live system artifacts, not annual documentation projects
Access controls that satisfy FATF AML Recommendations requirements for Pharmaceuticals & Life Sciences data handling
Audit logging that generates evidence meeting FATF AML Recommendations audit standards in Pharmaceuticals & Life Sciences regulatory contexts
Incident response procedures aligned to FATF AML Recommendations notification and reporting timelines
Third-party vendor compliance documentation satisfying FATF AML Recommendations supply chain requirements
We implement FATF AML Recommendations compliance for Pharmaceuticals & Life Sciences clients by mapping the framework's requirements to the specific operational context of Pharmaceuticals & Life Sciences organizations before writing application code. Controls are implemented through infrastructure-as-code, enforced automatically by ALICE at every commit, and documented through automated evidence generation pipelines. The result is a FATF AML Recommendations-compliant Pharmaceuticals & Life Sciences system delivered on a fixed-price timeline.
Ready to build FATF AML Recommendations compliance into your Pharmaceuticals & Life Sciences system?
We build compliance architecture for Pharmaceuticals & Life Sciences organizations — FATF AML Recommendations and the full Pharmaceuticals & Life Sciences compliance landscape — from the first infrastructure decision. Fixed price. Production delivery. No discovery phase.